Liposomal amphotericin B, AmBisome
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis
1979 • 850 citations
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
1985 • 412 citations
Nephrotoxicity of Amphotericin B
1964 • 334 citations
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients
1991 • 281 citations
Systemic candidiasis in cancer patients.
1984 • 276 citations
Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin B
1993 • 243 citations
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial
1991 • 236 citations
Antifungal Agents Useful in Therapy of Systemic Fungal Infections
1983 • 236 citations
Amphotericin B-resistant yeast infection in severely immunocompromised patients
1988 • 236 citations
Distribution and Activity of Amphotericin B in Humans
1985 • 228 citations
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
1991 • 205 citations
Liposomal amphotericin B in drug-resistant visceral leishmaniasis
1991 • 188 citations
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
1994 • 187 citations
Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single‐centre experience of 133 episodes in 116 patients
1994 • 174 citations
Amphotericin B Toxicity
1969 • 141 citations
Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections
1988 • 134 citations
Overview of liposomes
1991 • 129 citations
Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS
1993 • 119 citations
Rhinocerebral mucormycosis: Use of liposomal amphotericin B
1991 • 103 citations
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B
1991 • 102 citations
Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients
1991 • 97 citations
Treatment of invasive aspergillosis
1994 • 90 citations
New strategies in fungal disease
1992 • 82 citations
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
1993 • 57 citations
Liposomal Amphotericin-B (AmBisome) for Treatment of Disseminated Fungal Infections in Two Infants of Very Low Birth Weight
1992 • 54 citations
Antifungal chemotherapy
1981 • 50 citations
Cost-Effectiveness Analysis of Treatment with Liposomal Amphotericin B versus Conventional Amphotericin B in Organ or Bone Marrow Transplant Recipients with Systemic Mycoses
1992 • 42 citations
Eradication of Fusarium infection in a leukopenic patient treated with liposomal amphotericin B
1991 • 27 citations
Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin
1991 • 24 citations
Antifungal chemotherapy in patients with acquired immunodeficiency syndrome
1992 • 13 citations